These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28748474)

  • 21. Mass Spectrometry-Based Biomarker Discovery.
    Zhou W; Petricoin EF; Longo C
    Methods Mol Biol; 2017; 1606():297-311. PubMed ID: 28502008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted proteomics for cancer biomarker verification and validation.
    Ogata S; Masuda T; Ito S; Ohtsuki S
    Cancer Biomark; 2022; 33(4):427-436. PubMed ID: 35491770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biomarker discovery: success as a function of risk mitigation.
    Weiser S
    Scand J Clin Lab Invest Suppl; 2016; 245():S12-6. PubMed ID: 27426622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of proteins in urine samples using targeted mass spectrometry methods.
    Khristenko N; Domon B
    Methods Mol Biol; 2015; 1243():207-20. PubMed ID: 25384748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SILAC for biomarker discovery.
    Dittmar G; Selbach M
    Proteomics Clin Appl; 2015 Apr; 9(3-4):301-6. PubMed ID: 25504673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted proteomics strategy applied to biomarker evaluation.
    Kim YJ; Gallien S; van Oostrum J; Domon B
    Proteomics Clin Appl; 2013 Dec; 7(11-12):739-47. PubMed ID: 24123942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomarker discovery in mass spectrometry-based urinary proteomics.
    Thomas S; Hao L; Ricke WA; Li L
    Proteomics Clin Appl; 2016 Apr; 10(4):358-70. PubMed ID: 26703953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sampling and analytical strategies for biomarker discovery using mass spectrometry.
    Conrads TP; Hood BL; Veenstra TD
    Biotechniques; 2006 Jun; 40(6):799-805. PubMed ID: 16774124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging mass spectrometry in biomarker discovery and validation.
    Schwamborn K
    J Proteomics; 2012 Aug; 75(16):4990-4998. PubMed ID: 22749859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next-generation proteomics: toward customized biomarkers for environmental biomonitoring.
    Trapp J; Armengaud J; Salvador A; Chaumot A; Geffard O
    Environ Sci Technol; 2014 Dec; 48(23):13560-72. PubMed ID: 25345346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bead-Based Assays for Validating Proteomic Profiles in Body Fluids.
    Bendes A; Dale M; Mattsson C; Dodig-Crnković T; Iglesias MJ; Schwenk JM; Fredolini C
    Methods Mol Biol; 2021; 2344():65-78. PubMed ID: 34115352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining bioinformatics and MS-based proteomics: clinical implications.
    Acosta-Martin AE; Lane L
    Expert Rev Proteomics; 2014 Jun; 11(3):269-84. PubMed ID: 24720436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Qualification and Verification of Protein Biomarker Candidates.
    Zhao Y; Brasier AR
    Adv Exp Med Biol; 2016; 919():493-514. PubMed ID: 27975232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
    Turtoi A; Mazzucchelli GD; De Pauw E
    Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel TIA biomarkers identified by mass spectrometry-based proteomics.
    George PM; Mlynash M; Adams CM; Kuo CJ; Albers GW; Olivot JM
    Int J Stroke; 2015 Dec; 10(8):1204-11. PubMed ID: 26307429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers.
    Ackermann BL; Berna MJ
    Expert Rev Proteomics; 2007 Apr; 4(2):175-86. PubMed ID: 17425454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ICP-MS for multiplex absolute determinations of proteins.
    Sanz-Medel A
    Anal Bioanal Chem; 2010 Nov; 398(5):1853-9. PubMed ID: 20711768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.
    Robinson RA; Amin B; Guest PC
    Adv Exp Med Biol; 2017; 974():21-48. PubMed ID: 28353223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation.
    Lemoine J; Fortin T; Salvador A; Jaffuel A; Charrier JP; Choquet-Kastylevsky G
    Expert Rev Mol Diagn; 2012 May; 12(4):333-42. PubMed ID: 22616699
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.